vs

Side-by-side financial comparison of MODIV INDUSTRIAL, INC. (MDV) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $11.1M, roughly 1.2× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -73.9%, a 84.8% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -5.6%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -3.8%).

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

MDV vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.2× larger
TLSI
$13.2M
$11.1M
MDV
Growing faster (revenue YoY)
TLSI
TLSI
+65.4% gap
TLSI
59.8%
-5.6%
MDV
Higher net margin
MDV
MDV
84.8% more per $
MDV
11.0%
-73.9%
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-3.8%
MDV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDV
MDV
TLSI
TLSI
Revenue
$11.1M
$13.2M
Net Profit
$1.2M
$-9.8M
Gross Margin
86.7%
Operating Margin
45.8%
-24.8%
Net Margin
11.0%
-73.9%
Revenue YoY
-5.6%
59.8%
Net Profit YoY
-22.0%
3.5%
EPS (diluted)
$0.02
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDV
MDV
TLSI
TLSI
Q4 25
$11.1M
$13.2M
Q3 25
$11.7M
$11.6M
Q2 25
$11.8M
$11.2M
Q1 25
$11.8M
$9.2M
Q4 24
$11.7M
$8.3M
Q3 24
$11.7M
$7.3M
Q2 24
$11.4M
$7.4M
Q1 24
$12.0M
$6.5M
Net Profit
MDV
MDV
TLSI
TLSI
Q4 25
$1.2M
$-9.8M
Q3 25
$1.0M
$-10.8M
Q2 25
$-2.0M
$-8.3M
Q1 25
$829.0K
$-10.4M
Q4 24
$1.6M
$-10.1M
Q3 24
$-587.0K
$-2.4M
Q2 24
$1.3M
$-4.3M
Q1 24
$3.7M
$-13.2M
Gross Margin
MDV
MDV
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
MDV
MDV
TLSI
TLSI
Q4 25
45.8%
-24.8%
Q3 25
41.4%
-77.9%
Q2 25
9.8%
-65.4%
Q1 25
40.2%
-79.9%
Q4 24
45.4%
-91.8%
Q3 24
42.0%
-118.9%
Q2 24
44.6%
-111.0%
Q1 24
55.6%
-180.8%
Net Margin
MDV
MDV
TLSI
TLSI
Q4 25
11.0%
-73.9%
Q3 25
9.0%
-93.5%
Q2 25
-17.1%
-73.9%
Q1 25
7.0%
-113.2%
Q4 24
13.3%
-122.4%
Q3 24
-5.0%
-32.6%
Q2 24
11.6%
-58.8%
Q1 24
31.1%
-204.5%
EPS (diluted)
MDV
MDV
TLSI
TLSI
Q4 25
$0.02
$-0.22
Q3 25
$0.00
$-0.96
Q2 25
$-0.32
$-0.27
Q1 25
$-0.01
$-0.39
Q4 24
$0.07
$-0.38
Q3 24
$-0.18
$-0.12
Q2 24
$0.03
$-0.21
Q1 24
$0.33
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDV
MDV
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$14.4M
$20.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$162.7M
$-33.9M
Total Assets
$476.5M
$35.3M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDV
MDV
TLSI
TLSI
Q4 25
$14.4M
$20.4M
Q3 25
$8.3M
$22.7M
Q2 25
$5.8M
$26.5M
Q1 25
$6.2M
$13.0M
Q4 24
$11.5M
$8.5M
Q3 24
$6.8M
$11.3M
Q2 24
$18.9M
$16.5M
Q1 24
$18.4M
$4.0M
Total Debt
MDV
MDV
TLSI
TLSI
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$279.8M
Q3 24
$279.7M
Q2 24
$279.7M
Q1 24
$279.6M
Stockholders' Equity
MDV
MDV
TLSI
TLSI
Q4 25
$162.7M
$-33.9M
Q3 25
$164.8M
$-26.7M
Q2 25
$165.6M
$-19.4M
Q1 25
$171.1M
$-34.4M
Q4 24
$190.1M
$-25.9M
Q3 24
$186.3M
$-20.4M
Q2 24
$187.0M
$-25.3M
Q1 24
$188.0M
$-36.0M
Total Assets
MDV
MDV
TLSI
TLSI
Q4 25
$476.5M
$35.3M
Q3 25
$499.6M
$36.5M
Q2 25
$498.9M
$41.3M
Q1 25
$506.8M
$28.6M
Q4 24
$507.8M
$24.0M
Q3 24
$507.4M
$27.5M
Q2 24
$519.5M
$32.4M
Q1 24
$522.5M
$17.9M
Debt / Equity
MDV
MDV
TLSI
TLSI
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
1.47×
Q3 24
1.50×
Q2 24
1.50×
Q1 24
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDV
MDV
TLSI
TLSI
Operating Cash FlowLast quarter
$15.0M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDV
MDV
TLSI
TLSI
Q4 25
$15.0M
$-2.5M
Q3 25
$4.1M
$-3.7M
Q2 25
$3.9M
$-7.3M
Q1 25
$3.0M
$-4.5M
Q4 24
$18.2M
$-5.7M
Q3 24
$5.1M
$-10.8M
Q2 24
$4.7M
$-13.4M
Q1 24
$3.0M
$-10.9M
Free Cash Flow
MDV
MDV
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
MDV
MDV
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
MDV
MDV
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
MDV
MDV
TLSI
TLSI
Q4 25
12.34×
Q3 25
3.95×
Q2 25
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons